Dose equivalents of antidepressants: Evidence-based recommendations from randomized controlled trials.
暂无分享,去创建一个
T. Furukawa | S. Leucht | A. Cipriani | C. Barbui | Y. Ogawa | N. Takeshima | Y. Hayasaka | M. Purgato | Laura R Magni | L. R. Magni
[1] T. Furukawa,et al. Dose Equivalents for Second-Generation Antipsychotic Drugs: The Classical Mean Dose Method. , 2015, Schizophrenia bulletin.
[2] S. Woods,et al. Dose equivalents for second-generation antipsychotics: the minimum effective dose method. , 2014, Schizophrenia bulletin.
[3] Thomas R. E. Barnes,et al. How to compare doses of different antipsychotics: A systematic review of methods , 2013, Schizophrenia Research.
[4] Andrea Cipriani,et al. Fluoxetine versus other types of pharmacotherapy for depression. , 2013, The Cochrane database of systematic reviews.
[5] Joseph Beyene,et al. Ratio of geometric means to analyze continuous outcomes in meta‐analysis: comparison to mean differences and ratio of arithmetic means using empiric data and simulation , 2012, Statistics in medicine.
[6] K. Lohr,et al. P-1102 - Comparative Effectiveness of Second Generation Antidepressants in the Pharmacologic Treatment of Adult Depression , 2011, European Psychiatry.
[7] J. Sterne,et al. The Cochrane Collaboration’s tool for assessing risk of bias in randomised trials , 2011, BMJ : British Medical Journal.
[8] Howard Balshem,et al. GRADE guidelines: 3. Rating the quality of evidence. , 2011, Journal of clinical epidemiology.
[9] R. Baldessarini,et al. International consensus study of antipsychotic dosing. , 2010, The American journal of psychiatry.
[10] D. Segal. Diagnostic and Statistical Manual of Mental Disorders (DSM-IV-TR) , 2010 .
[11] J. Geddes,et al. Comparative efficacy and acceptability of 12 new-generation antidepressants: a multiple-treatments meta-analysis , 2009, The Lancet.
[12] R. Hansen,et al. Controlling for Drug Dose in Systematic Review and Meta-Analysis: A Case Study of the Effect of Antidepressant Dose , 2009, Medical decision making : an international journal of the Society for Medical Decision Making.
[13] Joseph Beyene,et al. The ratio of means method as an alternative to mean differences for analyzing continuous outcome variables in meta-analysis: A simulation study , 2008 .
[14] Douglas G Altman,et al. Empirical evidence of bias in treatment effect estimates in controlled trials with different interventions and outcomes: meta-epidemiological study , 2008, BMJ : British Medical Journal.
[15] G. Simpson,et al. A 1-year double-blind study of 2 doses of long-acting risperidone in stable patients with schizophrenia or schizoaffective disorder. , 2006, The Journal of clinical psychiatry.
[16] G. Currier,et al. Introduction: Methods, Commentary, and Summary , 2005 .
[17] P. Buckley. Dosing equivalency of second-generation antipsychotic medications. , 2005, Journal of clinical psychopharmacology.
[18] John M. Davis,et al. Dose Response and Dose Equivalence of Antipsychotics , 2004, Journal of clinical psychopharmacology.
[19] S. Woods,et al. Chlorpromazine equivalent doses for the newer atypical antipsychotics. , 2003, The Journal of clinical psychiatry.
[20] M. Morrell,et al. The Expert Consensus Guideline Series Treatment of Epilepsy , 2001, Epilepsy & Behavior.
[21] M. Fava,et al. Definition and epidemiology of treatment-resistant depression. , 1996, The Psychiatric clinics of North America.
[22] E. Robins,et al. Research diagnostic criteria: rationale and reliability. , 1978, Archives of general psychiatry.
[23] T. Furukawa,et al. Paroxetine versus other anti-depressive agents for depression. , 2007, The Cochrane database of systematic reviews.
[24] J. Kane,et al. The expert consensus guideline series. Optimizing pharmacologic treatment of psychotic disorders. Introduction: methods, commentary, and summary. , 2003, The Journal of clinical psychiatry.
[25] J. Kane,et al. Optimizing pharmacologic treatment of psychotic disorders , 2003 .
[26] I. M. Ali. Long-term treatment with antidepressants in primary care , 1998 .
[27] Organización Mundial de la Salud. Guidelines for ATC classification and DDD assignment , 1996 .
[28] L. Hollister. Second-generation antidepressants. , 1982, Rational drug therapy.
[29] John M. Davis. Dose equivalence of the anti-psychotic drugs , 1974 .
[30] J. Davis,et al. Dose equivalence of the antipsychotic drugs. , 1974, Journal of psychiatric research.
[31] J. Feighner,et al. Diagnostic criteria for use in psychiatric research. , 1972, Archives of general psychiatry.